Skandinaviska Enskilda Banken AB (publ) - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,705
+10.6%
59,6260.0%0.02%
+12.5%
Q2 2023$2,446
+262.9%
59,626
+216.2%
0.02%
+220.0%
Q1 2023$674
-9.5%
18,856
-4.5%
0.01%
-16.7%
Q4 2022$745
-99.9%
19,736
-5.5%
0.01%
-14.3%
Q3 2022$923,000
+19.4%
20,8780.0%0.01%
+16.7%
Q2 2022$773,0000.0%20,8780.0%0.01%
+20.0%
Q1 2022$773,000
+21.2%
20,8780.0%0.01%
+66.7%
Q4 2021$638,000
-8.9%
20,8780.0%0.00%
-25.0%
Q3 2021$700,000
-45.7%
20,878
-35.3%
0.00%
-50.0%
Q2 2021$1,288,000
-47.4%
32,293
-40.7%
0.01%
-50.0%
Q1 2021$2,450,000
-0.6%
54,493
+25.0%
0.02%
-5.9%
Q4 2020$2,465,000
+19.0%
43,604
-0.1%
0.02%
+13.3%
Q3 2020$2,072,000
-62.9%
43,659
-53.8%
0.02%
-66.7%
Q2 2020$5,578,000
+35.0%
94,600
+8.2%
0.04%
+114.3%
Q1 2020$4,132,000
-28.7%
87,400
-9.0%
0.02%
-54.3%
Q4 2019$5,799,000
+2.3%
96,000
+1.5%
0.05%
-4.2%
Q3 2019$5,667,000
+987.7%
94,600
+1067.9%
0.05%
+1100.0%
Q2 2019$521,000
+101.2%
8,100
+26.6%
0.00%
+33.3%
Q1 2016$259,000
-71.3%
6,400
-56.5%
0.00%
-75.0%
Q4 2015$901,00014,7000.01%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,510,173$159,221,4478.52%
Bellevue Group AG 9,233,700$418,840,6326.75%
Deep Track Capital, LP 2,834,069$128,553,3704.96%
BVF INC/IL 4,004,613$181,649,2464.90%
Sicart Associates LLC 203,132$9,214,0683.61%
Camber Capital Management LP 2,250,000$102,0603.36%
Privium Fund Management B.V. 228,493$10,364,4433.08%
Orbimed Advisors 2,169,500$98,408,5202.09%
SECTOR GAMMA AS 165,616$7,512,3421.92%
TANAKA CAPITAL MANAGEMENT INC 14,612$6631.89%
View complete list of IONIS PHARMACEUTICALS INC shareholders